Visual impairment certification secondary to ARMD in Leeds, 2005-2010: Is the incidence falling?

Eye (Basingstoke)

Volumn 26, Issue 7, 2012, Pages 933-936

  Rostron, E ^a   McKibbin, M ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

age related macular degeneration; ARMD; visual impairment certification

Indexed keywords

RANIBIZUMAB;

ARTICLE; HUMAN; INCIDENCE; RETINA MACULA AGE RELATED DEGENERATION; RETROSPECTIVE STUDY; VISUAL IMPAIRMENT;

EID: 84863882859     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2012.61     Document Type: Article

References (15)

1. Owen CG, Fletcher AE, Donoghue M, Rudnicka AR. How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom? Br J Ophthalmol 2003; 87: 312-317. (Pubitemid 36307906)
2. Kanski JJ, Bowling B. Age-related macular degeneration. In: Kanski JJ, Bowling B (eds). Clinical Ophthalmology: A Systematic Approach 7th ed. Saunders: London, 2011, 611-616.
3. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995; 39(5): 367-374.
4. Mitchell P, Korobelnik JF, Lanzetta P, Holz FG, Prunte C, Schmidt-Erfurth U et al. Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials. Br J Ophthalmol 2010; 94: 2-13.
5. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996; 80: 9-14. (Pubitemid 26017552)
6. Bunce C, Wormald R. Leading causes of certification for blindness and partial sight in England & Wales. BMC Public Health 2006; 6: 58.
7. Sorsby A. The incidence and causes of blindness in England and Wales 1948-1962. Reports on Public Health and Medical Subjects, No. 114. HMSO: London, 1966.
8. Sorsby A. The Incidence and causes of blindness in England and Wales 1963-1968. Reports on Public Health and Medical Subjects, No. 128. HMSO: London, 1972.
9. Department of Health. Form CVI: explanatory notes for consultants ophthalmologists and hospital eye clinic staff. Guidance, 2003. Available from http://www.dh.gov.uk.
10. Department of Health. Coordinating Services for Visually Handicapped People: Report to the Minister for the Disabled. HMSO: London, 1989.
11. Cormack TG, Grant B, Macdonald MJ, Steel J, Campbell IW. Incidence of blindness due to diabetic eye disease in Fife 1990-9. Br J Ophthalmol 2001; 85(3): 354-356. (Pubitemid 32250770)
12. Bunce C, Xing W, Wormald R. Causes of blind and partial sight certifications in England and Wales: April 2007-March 2008. Eye 2010; 24(11): 1692-1699.
13. Robinson R, Deutsch J, Jones HS, Youngson-Reilly S, Hamlin DM, Dhurjon L et al. Unrecognised and unregistered visual impairment. Br J Ophthalmol 1994; 78: 736-740. (Pubitemid 24311507)
14. Rostron E, McKibbin M. Trends in the incidence of visual impairment certification due to ARMD. Poster presentation. Annual Congress of the Royal College of Ophthalmologists 2011.
15. Rosenfeld PJ, Shapiro H, Tuomi L, Webster M, Elledge J, Blodi B. MARINA and ANCHOR Study Groups. Characteristics of patients losing vision after 2 years of monthly dosing in the phase III ranibizumab clinical trials. Ophthalmology 2011; 118(3): 523-530.